The European Union could spend more than $ 10 billion on the purchase of coronavirus vaccines developed by pharmaceutical companies Pfizer-BioNTech and CureVac. The EU will pay less for one dose than the US for the initial supply of the vaccine, Reuters reported, citing an EU official involved in the negotiations.
According to the interlocutor of the agency, the European Union intends to buy hundreds of millions of doses of vaccines.
For each vaccine dose from Pfizer and BioNTech, the EU agreed to pay $18.34 (€15.5).
The total cost for 200 million doses will be $3.7 billion, and if another 100 million doses are purchased, it will increase to $5.5 billion. At the same time, the EU will pay less for the first deliveries than in the US.
For the first deliveries of 225 million doses of CureVac vaccine, the EU is willing to pay $11.84 (10 euros).
Prior to that, it became known that the Ministry of Health is negotiating with six companies on a vaccine. The Ministry of Health will not be able to provide the entire population of the country with a vaccine against coronavirus at the expense of only one manufacturer.